Quick Answer
Anbio Biotechnology reported R&D Expense of $454.2 thousand for fiscal year 2024.
Anbio Biotechnology R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $454.2K | +237.2% |
| 2023 | $134.7K | -32.6% |
| 2022 | $200.0K | — |
- Anbio Biotechnology showed an increase of +237.2% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2024 period, Anbio Biotechnology’s r&d expense has grown by 127.1% (from $200.0 thousand to $454.2 thousand).
- The most recent figure is from Anbio Biotechnology’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: